Side Effects of Meleya (Norethindrone) Birth Control
The most common side effect of Meleya is irregular menstrual bleeding, including frequent and irregular bleeding patterns, while other side effects include headache, breast tenderness, nausea, and dizziness. 1
Primary Side Effects
Menstrual Irregularities (Most Frequent)
- Irregular bleeding is the most frequently reported side effect 1
- Frequent and irregular bleeding are common
- Breakthrough bleeding and spotting occur regularly
- Long duration bleeding episodes (less common)
- Amenorrhea (less common)
- Delayed withdrawal bleeding when the product is stopped 1
Common Systemic Side Effects
The following occur with increased frequency in progestin-only pill users 1:
- Headache
- Breast tenderness and breast pain
- Nausea (though less common than with combined oral contraceptives)
- Dizziness
- Fatigue
- Edema (fluid retention)
Androgenic Effects (Rare)
These occur rarely with norethindrone 1:
- Acne
- Hirsutism (excess hair growth)
- Weight gain
Psychiatric Effects
- Depression
- Nervousness
- Anxiety (research suggests norethindrone alone may have higher anxiety rates compared to combination pills) 2
Other Reported Side Effects
From clinical trials and post-marketing surveillance 1:
- Gastrointestinal: Vomiting, abdominal pain
- Musculoskeletal: Pain in extremities
- Reproductive: Genital discharge, menorrhagia, vaginal hemorrhage, suppressed lactation
- Dermatologic: Alopecia (hair loss), rash, pruritic rash
- Hepatic: Hepatitis, cholestatic jaundice (rare)
- Immune: Anaphylactic/anaphylactoid reactions, hypersensitivity (rare)
Serious Warnings
Cardiovascular Risk
Cigarette smoking increases the risk of serious cardiovascular disease—women using Meleya should be strongly advised not to smoke 1
Ectopic Pregnancy Risk
- The incidence of ectopic pregnancy is 5 per 1,000 woman-years
- Up to 10% of pregnancies in progestin-only pill users are extrauterine
- Watch for lower abdominal pain as a warning sign 1
Ovarian Cysts
- Delayed follicular atresia can occur
- Follicles may grow larger than normal and persist
- Usually asymptomatic and resolve spontaneously
- Rarely may twist or rupture, requiring surgical intervention 1
Cancer Considerations
- Some studies suggest increased relative risk of breast cancer, particularly with younger age and longer duration of use
- Women with breast cancer should not use this contraceptive
- Possible association with cervical intraepithelial neoplasia 1
Clinical Context
Discontinuation rates are substantial—48.5% in one adolescent study, with irregular bleeding being the most common reason (54.5% of discontinuations) 3. Research shows that irregular bleeding and systemic side effects are significantly associated with discontinuation (P=0.006 and P=0.003 respectively) 3.
The 2024 CDC guidelines recommend exploring patient goals when bleeding irregularities occur, providing reassurance for those who wish to continue, and offering NSAIDs for 5-7 days as treatment if desired 4.
Important caveat: Unlike combined hormonal contraceptives, norethindrone does not contain estrogen, so the serious cardiovascular and thromboembolic risks associated with estrogen are not present 1. However, efficacy depends on rigid adherence to the dosing schedule, as serum levels return to near baseline by 24 hours after ingestion 1.